Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Infectious Diseases
  4. STIs

STIs

  • Antimicrobial Stewardship (20)
  • COVID-19 (33)
  • Fever (5)
  • Fungal Infections (7)
  • H1N1 (Swine) Influenza (40)
  • HIV & AIDS (87)
  • Infections (57)
  • Lower Respiratory Tract Infections (119)
  • Measles (4)
  • MRSA (5)
  • Other (213)
  • Resources (565)
  • STIs (101)
    • Chlamydia (6)
    • Genital Herpes (Herpes simplex) (2)
    • Gonorrhea (16)
    • Hepatitis (35)
    • Herpes (3)
    • HPV (24)
    • Other STIs (8)
    • Prevention (23)
    • Syphilis (6)
    • Trichomonas (2)
  • Skin/Soft Tissue Infections (80)
  • Thrush (1)
  • Travel Medicine (87)
  • Upper Respiratory Tract Infections (173)
  • Vaccines (286)
  • West Nile Virus (9)
16 - 30 of 101 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Know How Descovy and Truvada Stack Up for HIV Pre-Exposure Prophylaxis (PrEP) November 2019
Article: Be Vigilant When Screening for Drug Interactions With Hep C Meds July 2019
Chart: Hepatitis C Treatment Overview July 2019
Article: Tell Patients to Be Persistent When Treating Warts June 2019
Article: Emphasize Adherence With Pre-Exposure Prophylaxis for HIV May 2018
Article: Recommend a Hep B Booster in Some High-Risk Patients May 2018
Chart: Hepatitis B Vaccination: Who Gets What and When? May 2018
Article: Get Ready for Hep C Meds Maviret and Vosevi October 2017
Article: Recommend Gentamicin if a Cephalosporin Is Not an Option for Gonorrhea October 2017
PL Voices: Pre-Exposure Prophylaxis for HIV Prevention May 2017
Guideline: Preexposure Prophylaxis for the Prevention of HIV Infection U.S. (2017) May 2017
Commentary: Risk of Hepatitis B Reactivation With Hepatitis C Drugs April 2017
Article: Put Warnings About Liver Damage With Hep C Meds Into Perspective April 2017
Article: Limit PPI Doses With New Hep C Med Epclusa September 2016
Article: Watch for Insurance Flags or Rejects for Specialty Meds April 2016
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved